Alembic Pharmaceuticals Limited (NSE:APLLTD)

Alembic Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Alembic Pharmaceuticals had annual revenue of 73.45B INR with 10.08% growth. Alembic Pharmaceuticals had revenue of 18.48B in the quarter ending March 31, 2026, with 4.41% growth.

• Revenue: 73.45B
• Revenue Growth: +10.08%
• P/S Ratio: 2.24
• Revenue / Employee: 4.43M
• Employees: 16,571
• Market Cap: 164.60B

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	73.45B	6.73B	10.08%
Mar 31, 2025	66.72B	4.43B	7.12%
Mar 31, 2024	62.29B	5.76B	10.19%
Mar 31, 2023	56.53B	3.47B	6.54%
Mar 31, 2022	53.06B	-873.40M	-1.62%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 11, 2026

Data Sources Report a data error